Royal Phillips will introduce its latest interventional oncology solution, OncoSuite for minimally invasive treatment of liver cancer.

OncoSuite is designed as an integrated solution to improve tumour embolisation and ablation procedures using Philips’ interventional X-ray systems and allows the physicians to target multiple tumour lesions simultaneously.

It is characterised by the company’s products for enhanced imaging (XperCT Dual), live 3D image guidance for tumour embolisation (EmboGuide) and live 3D image guidance for tumour ablation (XperGuide).

OncoSuite enables targeted treatment of an entire tumour and its feeder vessels without affecting the surrounding tissue or organs.

Its XperCT Dual feature enables better centering of the liver offering an improved visibility during the procedure of peripheral hepatic tumours in a single sweep and facilitating the ability to scan larger patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

It also features LC Bead LUMI which offers visible confirmation of bead location during embolisation procedures in real time.

Additionally, OncoSuite is integrated with the new Wiper Movement to improve workflow with automatic Dual Phase imaging, enabling the physicians to get two 3D cone beam CT datasets at different times during the procedure.

"The new suite of solutions emphasises minimally invasive procedures to aid the physician’s decision for an appropriate therapy for each patient."

The new suite of solutions emphasises minimally invasive procedures to aid the physician’s decision for an appropriate therapy for each patient.

Philips image guided therapy systems business leader Ronald Tabaksblat said: “Minimally invasive, image-guided interventional oncology procedures are a highly effective option for patients who cannot be treated through conventional techniques such as surgery, chemotherapy or radiation therapy.

“Interventional oncology procedures are rapidly increasing and OncoSuite provides the first complete interventional oncology portfolio for interventional radiologists, enabling physicians to see the entire tumor and its feeder vessels to directly target treatment avoiding healthy tissue.”

Image: Surgeons carrying out treatment. Photo: courtesy of Koninklijke Philips N.V.